NASDAQ:BYSI

BeyondSpring News Headlines

$10.24
-0.05 (-0.49 %)
(As of 04/12/2021 12:00 AM ET)
Add
Compare
Today's Range
$10.20
Now: $10.24
$10.53
50-Day Range
$10.27
MA: $11.99
$14.92
52-Week Range
$9.83
Now: $10.24
$21.50
Volume174,159 shs
Average Volume273,663 shs
Market Capitalization$400.81 million
P/E RatioN/A
Dividend YieldN/A
Beta0.6

Headlines

BeyondSpring (NASDAQ BYSI) News Headlines Today

SourceHeadline
What Is The Ownership Structure Like For BeyondSpring Inc. (NASDAQ:BYSI)? - NasdaqWhat Is The Ownership Structure Like For BeyondSpring Inc. (NASDAQ:BYSI)? - Nasdaq
nasdaq.com - April 9 at 7:51 PM
BeyondSpring downgraded at H.C. Wainwright despite a potential launch of Plinabulin - Seeking AlphaBeyondSpring downgraded at H.C. Wainwright despite a potential launch of Plinabulin - Seeking Alpha
seekingalpha.com - April 5 at 5:52 PM
Focus on equipment makers as Citi unveils positive catalyst watch; Invitae upgraded on Softbank investment and more in today’s analyst action - Seeking AlphaFocus on equipment makers as Citi unveils positive catalyst watch; Invitae upgraded on Softbank investment and more in today’s analyst action - Seeking Alpha
seekingalpha.com - April 5 at 12:43 PM
HC Wainwright Downgrades BeyondSpring (NASDAQ:BYSI) to NeutralHC Wainwright Downgrades BeyondSpring (NASDAQ:BYSI) to Neutral
americanbankingnews.com - April 5 at 8:40 AM
BeyondSpring (NASDAQ:BYSI) Rating Lowered to Neutral at HC WainwrightBeyondSpring (NASDAQ:BYSI) Rating Lowered to Neutral at HC Wainwright
americanbankingnews.com - April 5 at 8:02 AM
A Peek Into The Markets: US Stock Futures Gain After Upbeat Jobs Data - BenzingaA Peek Into The Markets: US Stock Futures Gain After Upbeat Jobs Data - Benzinga
benzinga.com - April 5 at 7:43 AM
-$0.95 EPS Expected for BeyondSpring Inc. (NASDAQ:BYSI) This Quarter-$0.95 EPS Expected for BeyondSpring Inc. (NASDAQ:BYSI) This Quarter
americanbankingnews.com - April 4 at 10:18 PM
BeyondSpring files plinabulin + G-CSF application in U.S. and China - Seeking AlphaBeyondSpring files plinabulin + G-CSF application in U.S. and China - Seeking Alpha
seekingalpha.com - April 1 at 8:10 PM
BeyondSpring Files US-China Application For Plinabulin G-CSF Treatment In Chemo-Induced Neutropenia - Yahoo FinanceBeyondSpring Files US-China Application For Plinabulin G-CSF Treatment In Chemo-Induced Neutropenia - Yahoo Finance
finance.yahoo.com - April 1 at 8:10 PM
BeyondSpring Files US-China Application For Plinabulin G-CSF Treatment In Chemo-Induced NeutropeniaBeyondSpring Files US-China Application For Plinabulin G-CSF Treatment In Chemo-Induced Neutropenia
finance.yahoo.com - April 1 at 3:10 PM
Health Care Sector Update for 04/01/2021: SNOA, BYSI, CTIC, IYH, VHT, IBB - NasdaqHealth Care Sector Update for 04/01/2021: SNOA, BYSI, CTIC, IYH, VHT, IBB - Nasdaq
nasdaq.com - April 1 at 10:09 AM
BeyondSpring Announces Submission of New Drug Application to U.S. FDA and China NMPA for Plinabulin and G-CSF Combination for the Prevention of Chemotherapy-Induced Neutropenia (CIN) - GlobeNewswireBeyondSpring Announces Submission of New Drug Application to U.S. FDA and China NMPA for Plinabulin and G-CSF Combination for the Prevention of Chemotherapy-Induced Neutropenia (CIN) - GlobeNewswire
globenewswire.com - April 1 at 12:07 AM
BeyondSpring Announces Submission of New Drug Application to U.S. FDA and China NMPA for Plinabulin and G-CSF Combination for the Prevention of Chemotherapy-Induced Neutropenia (CIN)BeyondSpring Announces Submission of New Drug Application to U.S. FDA and China NMPA for Plinabulin and G-CSF Combination for the Prevention of Chemotherapy-Induced Neutropenia (CIN)
finance.yahoo.com - April 1 at 12:07 AM
Reviewing BeyondSpring (NASDAQ:BYSI) and Galectin Therapeutics (NASDAQ:GALT)Reviewing BeyondSpring (NASDAQ:BYSI) and Galectin Therapeutics (NASDAQ:GALT)
americanbankingnews.com - March 26 at 12:36 AM
Sizing Up A Bet In BeyondSpring - Seeking AlphaSizing Up A Bet In BeyondSpring - Seeking Alpha
seekingalpha.com - March 25 at 8:07 PM
Is BeyondSpring Inc.s (NASDAQ:BYSI) Shareholder Ownership Skewed Towards Insiders? - Yahoo FinanceIs BeyondSpring Inc.'s (NASDAQ:BYSI) Shareholder Ownership Skewed Towards Insiders? - Yahoo Finance
finance.yahoo.com - March 21 at 2:54 PM
Is BeyondSpring Inc.s (NASDAQ:BYSI) Shareholder Ownership Skewed Towards Insiders?Is BeyondSpring Inc.'s (NASDAQ:BYSI) Shareholder Ownership Skewed Towards Insiders?
finance.yahoo.com - March 21 at 9:41 AM
BeyondSpring Hosting Key Opinion Leader Webinar on Plinabulin for the Prevention of Chemotherapy-Induced Neutropenia - GlobeNewswireBeyondSpring Hosting Key Opinion Leader Webinar on Plinabulin for the Prevention of Chemotherapy-Induced Neutropenia - GlobeNewswire
globenewswire.com - March 11 at 7:50 PM
BeyondSpring Hosting Key Opinion Leader Webinar on Plinabulin for the Prevention of Chemotherapy-Induced NeutropeniaBeyondSpring Hosting Key Opinion Leader Webinar on Plinabulin for the Prevention of Chemotherapy-Induced Neutropenia
finance.yahoo.com - March 11 at 7:50 PM
5 Top Stock Gainers for Wednesday: Bilibili, DermTech - TheStreet5 Top Stock Gainers for Wednesday: Bilibili, DermTech - TheStreet
thestreet.com - December 30 at 2:57 PM
Why Is It Moving? Analyzing The Upward Movement in BeyondSprings Stock Today - BenzingaWhy Is It Moving? Analyzing The Upward Movement in BeyondSpring's Stock Today - Benzinga
benzinga.com - December 29 at 1:59 PM
UPDATE -- BeyondSpring to Present at the J.P. Morgan Healthcare Conference on January 14, 2021 - Yahoo FinanceUPDATE -- BeyondSpring to Present at the J.P. Morgan Healthcare Conference on January 14, 2021 - Yahoo Finance
finance.yahoo.com - December 29 at 1:59 PM
UPDATE -- BeyondSpring to Present at the J.P. Morgan Healthcare Conference on January 14, 2021UPDATE -- BeyondSpring to Present at the J.P. Morgan Healthcare Conference on January 14, 2021
finance.yahoo.com - December 29 at 1:59 PM
BeyondSpring to Present at the J.P. Morgan Healthcare Conference on January 14, 2021 - Yahoo FinanceBeyondSpring to Present at the J.P. Morgan Healthcare Conference on January 14, 2021 - Yahoo Finance
finance.yahoo.com - December 29 at 8:59 AM
BeyondSpring to Present at the J.P. Morgan Healthcare Conference on January 14, 2021BeyondSpring to Present at the J.P. Morgan Healthcare Conference on January 14, 2021
finance.yahoo.com - December 29 at 8:59 AM
BeyondSpring Announces the Appointment of Dr. Jeffrey Vacirca to its Board of Directors - GlobeNewswireBeyondSpring Announces the Appointment of Dr. Jeffrey Vacirca to its Board of Directors - GlobeNewswire
globenewswire.com - December 17 at 9:33 AM
BeyondSpring: Would Be A Great Buy Except For The Perennial Need For Cash And Ensuing Dilution - Seeking AlphaBeyondSpring: Would Be A Great Buy Except For The Perennial Need For Cash And Ensuing Dilution - Seeking Alpha
seekingalpha.com - December 15 at 9:45 AM
BeyondSpring (BYSI) Reports New Positive PROTECTIVE-2 Phase 3 Registrational Trial Results - StreetInsider.comBeyondSpring (BYSI) Reports New Positive PROTECTIVE-2 Phase 3 Registrational Trial Results - StreetInsider.com
streetinsider.com - December 10 at 11:14 PM
BeyondSpring Announces New Positive PROTECTIVE-2 Phase 3 Registrational Trial Results at the 2020 San Antonio Breast Cancer Symposium - GlobeNewswireBeyondSpring Announces New Positive PROTECTIVE-2 Phase 3 Registrational Trial Results at the 2020 San Antonio Breast Cancer Symposium - GlobeNewswire
globenewswire.com - December 10 at 6:13 PM
BeyondSpring Announces New Positive PROTECTIVE-2 Phase 3 Registrational Trial Results at the 2020 San Antonio Breast Cancer SymposiumBeyondSpring Announces New Positive PROTECTIVE-2 Phase 3 Registrational Trial Results at the 2020 San Antonio Breast Cancer Symposium
finance.yahoo.com - December 10 at 6:13 PM
Do Hedge Funds Love BeyondSpring, Inc. (BYSI)? - Yahoo FinanceDo Hedge Funds Love BeyondSpring, Inc. (BYSI)? - Yahoo Finance
finance.yahoo.com - November 29 at 5:51 PM
Do Hedge Funds Love BeyondSpring, Inc. (BYSI)?Do Hedge Funds Love BeyondSpring, Inc. (BYSI)?
finance.yahoo.com - November 29 at 5:51 PM
BeyondSpring to Participate in Upcoming Evercore ISI 2020 ConferenceBeyondSpring to Participate in Upcoming Evercore ISI 2020 Conference
finance.yahoo.com - November 23 at 8:54 PM
BeyondSpring slides 9% on public offering pricing at $10.0/shareBeyondSpring slides 9% on public offering pricing at $10.0/share
seekingalpha.com - November 19 at 12:50 PM
BeyondSpring under pressure on shares offeringBeyondSpring under pressure on shares offering
seekingalpha.com - November 17 at 6:40 PM
BeyondSpring Announces Third Quarter 2020 Financial Results and Provides Business UpdatesBeyondSpring Announces Third Quarter 2020 Financial Results and Provides Business Updates
finance.yahoo.com - November 17 at 8:39 AM
BeyondSprings plinabulin combo meets primary endpoint in neutropenia trialBeyondSpring's plinabulin combo meets primary endpoint in neutropenia trial
seekingalpha.com - November 16 at 9:33 AM
BeyondSpring Announces Positive Topline Results from its PROTECTIVE-2 Phase 3 Registrational Trial of Plinabulin in Combination with Pegfilgrastim for Prevention of Chemotherapy-Induced NeutropeniaBeyondSpring Announces Positive Topline Results from its PROTECTIVE-2 Phase 3 Registrational Trial of Plinabulin in Combination with Pegfilgrastim for Prevention of Chemotherapy-Induced Neutropenia
finance.yahoo.com - November 16 at 9:33 AM
BeyondSpring to Present Corporate Overview at Jefferies London Healthcare ConferenceBeyondSpring to Present Corporate Overview at Jefferies London Healthcare Conference
finance.yahoo.com - November 13 at 5:55 PM
Seed Therapeutics, Eli Lilly in pact for protein degradation-based therapiesSeed Therapeutics, Eli Lilly in pact for protein degradation-based therapies
seekingalpha.com - November 13 at 7:50 AM
BeyondSpring Subsidiary, Seed Therapeutics, Announces Research Collaboration and License Agreement with LillyBeyondSpring Subsidiary, Seed Therapeutics, Announces Research Collaboration and License Agreement with Lilly
finance.yahoo.com - November 13 at 7:50 AM
Seed Therapeutics Launches Protein Degradation Research Platform and Appoints Edward Dongheng Liu as Chief Financial OfficerSeed Therapeutics Launches Protein Degradation Research Platform and Appoints Edward Dongheng Liu as Chief Financial Officer
markets.businessinsider.com - October 14 at 7:54 AM
BeyondSpring Forms Partnership Advisory Committee Comprised of Industry VeteransBeyondSpring Forms Partnership Advisory Committee Comprised of Industry Veterans
markets.businessinsider.com - October 12 at 9:15 AM
JAMA Oncology Highlights Plinabulins Efficacy in Preventing Chemotherapy-Induced Neutropenia as a MonotherapyJAMA Oncology Highlights Plinabulin's Efficacy in Preventing Chemotherapy-Induced Neutropenia as a Monotherapy
finance.yahoo.com - October 7 at 10:44 PM
JAMA Oncology Highlights Plinabulins Efficacy in Preventing Chemotherapy-Induced Neutropenia as a MonotherapyJAMA Oncology Highlights Plinabulin's Efficacy in Preventing Chemotherapy-Induced Neutropenia as a Monotherapy
markets.businessinsider.com - September 29 at 12:43 PM
BeyondSprings manuscript on Plinabulin published in JAMA OncologyBeyondSpring's manuscript on Plinabulin published in JAMA Oncology
seekingalpha.com - September 29 at 12:43 PM
Akero Continues Efruxifermin Trial, And Other News: The Good, Bad And Ugly Of BiopharmaAkero Continues Efruxifermin Trial, And Other News: The Good, Bad And Ugly Of Biopharma
seekingalpha.com - September 29 at 7:42 AM
BeyondSprings Plinabulin at par with Amgens pegfilgrastimBeyondSpring's Plinabulin at par with Amgen's pegfilgrastim
seekingalpha.com - September 24 at 11:49 PM
Additional data show BeyondSprings plinabulin at par with Amgens pegfilgrastimAdditional data show BeyondSpring's plinabulin at par with Amgen's pegfilgrastim
seekingalpha.com - September 24 at 1:48 PM
BeyondSprings Plinabulin effective in preventing life-threatening chemo-induced neutropeniaBeyondSpring's Plinabulin effective in preventing life-threatening chemo-induced neutropenia
seekingalpha.com - September 24 at 1:48 PM
This page was last updated on 4/13/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.